글로벌 샤가스병 치료 시장 – 2028년까지의 산업 동향 및 예측

샤가스병 치료 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 샤가스병 치료가 2021-2028년 예측 기간 동안 약 7.40%의 CAGR을 보일 것이라고 분석했습니다. 규제 당국의 특별 지정 승인 증가, 신약 및 치료법 개발을 위한 연구 개발 활동 급증 , 의료 인프라 개발 지출 증가 는 샤가스병 치료 시장 성장에 기여하는 주요 요인입니다.

미국 트리파노소마증이라고도 알려진 샤가스병은 원생동물 기생충에 의해 발생하는 염증성 감염성 질환입니다. 증상에는 근육통, 호흡곤란, 림프선 비대, 두통, 부기 등이 있습니다. 이 질병은 또한 심장 및 소화기 합병증으로 이어질 수 있습니다. 

농촌 지역에서 샤가스병의 유병률이 증가하는 것은 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가 와 질병 특정적 새로운 치료법 및 치료에 대한 수요 급증은 시장 성장을 촉진하는 다른 요인입니다. 개인의 가처분 소득 증가와 대변으로 오염된 조리되지 않은 음식의 소비 증가는 수익성 있는 시장 성장 기회를 창출할 다른 간접적인 결정 요인입니다.

그러나 개발도상국과 저개발 경제권에서 불리한 환불 시나리오는 시장 성장에 큰 도전이 될 것입니다. 또한 승인된 제품의 수가 제한되어 시장 성장률이 더욱 떨어질 것입니다. 후진 지역에서 증상에 대한 인식 부족도 시장 성장률을 멈추게 할 것입니다.

This chagas disease treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on chagas disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Chagas Disease Treatment Market Scope and Market Size

The chagas disease treatment market is segmented on the basis of type, treatment, drugs, route of administration, end users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the chagas disease treatment market is segmented into acute chagas disease and chronic chagas disease.
• On the basis of treatment, the chagas disease treatment market is segmented into antiparasitic treatment and symptomatic treatment.
• On the basis of drugs, the chagas disease treatment market is segmented into benznidazole and nifurtimox.
• On the basis of route of administration, the chagas disease treatment market is segmented into oral and injectable.
• On the basis of end users, the chagas disease treatment market is segmented into hospitals, homecare settings, specialty clinics, and others.
• On the basis of distribution channel, the chagas disease treatment market is segmented into hospital pharmacies, retail pharmacies and others.

Chagas Disease Treatment Market Country Level Analysis

The chagas disease treatment market is analysed and market size insights and trends are provided by country, type, treatment, drugs, route of administration, end users and distribution channel as referenced above.

The countries covered in the chagas disease treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the chagas disease treatment market owing to the rising expenditure for the development of research and development proficiencies, surge in the number of patients and favourable reimbursement scenario in this region. Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure, rising initiatives by the government to spread awareness and increasing personal disposable income.

The country section of the chagas disease treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The chagas disease treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Chagas Disease Treatment Market Share Analysis

The chagas disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to chagas disease treatment market.

샤가스병 치료 시장 보고서에 포함된 주요 기업으로는 Bayer AG, F. Hoffmann-La Roche Ltd, Astellas Pharma Inc, Sanofi, Pfizer Inc., DAIICHI SANKYO COMPANY, LIMITED, Novartis AG, AstraZeneca, Humanigen, Inc., Savant HWP, Eisai Co., Ltd, Oblita Therapeutics, GlaxoSmithKline plc, Collaborations Pharmaceuticals, Inc., Epichem Pty Ltd, Insud Pharma SLU, Kancera AB, Maprimed SA, Merck KGaA, QIAGEN 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-46671